News Announcement

Jagsonpal Pharmaceuticals: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Company as a part of its investors engagement activities has scheduled a conference call with the Analysts / Investors on Thursday January 22 2026 to discuss its Q3 FY26 financial results. The Conference call details is attached as Annexure.

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.